M. Dib

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics

Catherine Roche‐Lestienne, S. Lepers, Valérie Soenen et al. · Leukemia · 2005 · 106 citations

Life Sciences, Genetics, Molecular Biology +13

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Benjamin Hébraud, Xavier Leleu, V. Lauwers‐Cancès et al. · Leukemia · 2013 · 104 citations

Life Sciences, Genetics, Hematology +11

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

Philippe Moreau, Michel Attal, Frédéric Garban et al. · Leukemia · 2007 · 89 citations

Medicine, Hematology, Oncology +9

Major Superiority of Melphalan - Prednisone (MP) + Thalidomide (THAL) over MP and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients with Multiple Myeloma.

Thierry Façon, Jean‐Yves Mary, C. Hulin et al. · Blood · 2005 · 65 citations

Medicine, Hematology, Oncology +17

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients

M.-L. Chretien, Benjamin Hébraud, V. Cances-Lauwers et al. · Haematologica · 2014 · 49 citations · Full text

Medicine, Geriatric Medicine, Oncology +16